1. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range;Hirsh;Chest,2001
2. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety;Hirsh;Chest,2001
3. Thrombotic complications of anticoagulant therapy;Warketin,2001
4. The emerging role of low-molecular-weight heparin in cardiovascular medicine;Hirsh;Prog. Cardiovasc. Dis.,2000
5. Clot-bound thrombin is protected from inhibition by heparin–antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors;Weitz;J. Clin. Invest.,1990